Pfizer CEO confident vaccine supply will exceed needs by end of 2021
- 3 years ago
Pfizer Inc's chief executive, Albert Bourla, said on Wednesday he was confident that by the end of 2021 there would be more vaccine doses than required to fight the COVID-19 pandemic.
His remarks came after Britain approved a vaccine produced by Pfizer and its German biotechnology partner BioNTech on Wednesday. The two companies say their vaccine is 95% effective.
His remarks came after Britain approved a vaccine produced by Pfizer and its German biotechnology partner BioNTech on Wednesday. The two companies say their vaccine is 95% effective.